Indications for Hepamertz (lactulose)
Hepamertz (lactulose) is indicated for the prevention and treatment of portal-systemic encephalopathy, including hepatic pre-coma and coma [1]. Hepamertz (lactulose) is also indicated for the treatment of constipation [2].
Administration Duration for Portal-Systemic (Hepatic) Encephalopathy
Rapid improvement is expected after initiation, but clinical response may occur within 24 hours and may not begin before 48 hours or even later [1]. Hourly or more frequent dosing can be used in the initial phase to induce rapid laxation, followed by dose reduction to a maintenance daily dose once the target bowel pattern is achieved [1]. For acute treatment during impending coma or coma when aspiration risk exists, lactulose can be administered as a retention enema, and treatment continues until reversal of the coma stage allows oral therapy [1]. Continuous long-term therapy is indicated to lessen severity and prevent recurrence of portal-systemic encephalopathy [1].
Administration Duration for Constipation
For constipation, lactulose administration is continued until soft stools are formed [2]. Lactulose for constipation can be taken for as long as constipation lasts or as long as recommended by a clinician, with typical use usually up to a week [3]. For hepatic encephalopathy with constipation, longer courses may be recommended by a clinician [3].
Key Practical Targets Used to Guide Duration in Encephalopathy
In portal-systemic encephalopathy, dose adjustment is performed to produce the desired stool frequency and to achieve treatment goals [1]. In encephalopathy, the regimen is adjusted to target approximately 2 to 3 soft stools daily [1]. In encephalopathy, the dose may be reduced after the episode subsides and titrated to achieve maintenance stool frequency [2].
Pediatric Duration Considerations
If diarrhea persists after dose reduction in children and adolescents, lactulose should be discontinued [1].
When Dose Reduction or Discontinuation Is Indicated
If diarrhea becomes excessive, lactulose dosing should be reduced, because excessive dosage can lead to diarrhea and related complications such as dehydration and electrolyte abnormalities [1]. In pediatric patients with persistent diarrhea after dose reduction, discontinuation is indicated [1].
Administration Summary by Clinical Situation
Portal-systemic (hepatic) encephalopathy is treated with initial intensive dosing followed by maintenance therapy, with continuous long-term treatment indicated to prevent recurrence [1]. Constipation is treated with lactulose until soft stools are achieved, with duration commonly limited to days to about a week for uncomplicated constipation [2], [3].